Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $278K | Sell |
1,914
-643
| -25% | -$88.9K | ﹤0.01% | 162 |
|
|
2026
Q2 | $329K | Buy |
+2,557
| New | +$299K | 0.01% | 161 |
|
|
2026
Q1 | – | Sell |
-2,011
| Closed | -$212K | – | 187 |
|
|
2025
Q4 | $212K | Buy |
+2,011
| New | +$189K | ﹤0.01% | 158 |
|
|
2023
Q3 | – | Sell |
-2,400
| Closed | -$277K | – | 167 |
|
|
2023
Q2 | $277K | Sell |
2,400
-770
| -24% | -$87.4K | 0.01% | 146 |
|
|
2023
Q1 | $337K | Sell |
3,170
-242
| -7% | -$26.1K | 0.01% | 133 |
|
|
2022
Q4 | $379K | Sell |
3,412
-49
| -1% | -$5.01K | 0.01% | 151 |
|
|
2022
Q3 | $298K | Sell |
3,461
-14,428
| -81% | -$1.29M | 0.01% | 158 |
|
|
2022
Q2 | $1.63M | Buy |
17,889
+1,009
| +6% | +$89.4K | 0.06% | 132 |
|
|
2022
Q1 | $1.38M | Sell |
16,880
-3,620
| -18% | -$285K | 0.04% | 158 |
|
|
2021
Q4 | $1.57M | Sell |
20,500
-1,106
| -5% | -$88.1K | 0.04% | 167 |
|
|
2021
Q3 | $1.62M | Buy |
21,606
+5,109
| +31% | +$389K | 0.04% | 161 |
|
|
2021
Q2 | $1.28M | Sell |
16,497
-2,347
| -12% | -$175K | 0.03% | 192 |
|
|
2021
Q1 | $1.39M | Buy |
18,844
+1,677
| +10% | +$124K | 0.03% | 196 |
|
|
2020
Q4 | $1.34M | Sell |
17,167
-99,752
| -85% | -$7.63M | 0.03% | 201 |
|
|
2020
Q3 | $9.26M | Sell |
116,919
-14,547
| -11% | -$1.14M | 0.21% | 79 |
|
|
2020
Q2 | $9.7M | Hold |
131,466
| – | – | 0.32% | 62 |
|
|
2020
Q1 | $9.7M | Buy |
131,466
+10,067
| +8% | +$791K | 0.32% | 62 |
|
|
2019
Q4 | $10.5M | Sell |
121,399
-32,009
| -21% | -$2.63M | 0.28% | 61 |
|
|
2019
Q3 | $12.3M | Buy |
153,408
+6
| +0% | +$481 | 0.28% | 79 |
|
|
2019
Q2 | $12.3M | Buy |
153,402
+55,772
| +57% | +$4.27M | 0.27% | 80 |
|
|
2019
Q1 | $7.75M | Buy |
97,630
+11,738
| +14% | +$878K | 0.18% | 100 |
|
|
2018
Q4 | $6.26M | Sell |
85,892
-2,096
| -2% | -$148K | 0.11% | 121 |
|
|
2018
Q3 | $5.96M | Buy |
87,988
+12,157
| +16% | +$775K | 0.08% | 158 |
|
|
2018
Q2 | $4.39M | Sell |
75,831
-36,242
| -32% | -$2.04M | 0.06% | 199 |
|
|
2018
Q1 | $5.82M | Hold |
112,073
| – | – | 0.08% | 162 |
|
|
2017
Q4 | $6.02M | Hold |
112,073
| – | – | 0.08% | 181 |
|
|
2017
Q3 | $6.85M | Hold |
112,073
| – | – | 0.12% | 108 |
|
|
2017
Q2 | $6.85M | Buy |
112,073
+17,711
| +19% | +$1.08M | 0.2% | 100 |
|
|
2017
Q1 | $5.72M | Sell |
94,362
-18,969
| -17% | -$1.15M | 0.12% | 133 |
|
|
2016
Q4 | $6.37M | Sell |
113,331
-28,505
| -20% | -$1.67M | 0.16% | 68 |
|
|
2016
Q3 | $8.45M | Sell |
141,836
-29,659
| -17% | -$1.73M | 0.22% | 52 |
|
|
2016
Q2 | $9.43M | Sell |
171,495
-5,973
| -3% | -$318K | 0.24% | 50 |
|
|
2016
Q1 | $8.96M | Sell |
177,468
-82,478
| -32% | -$4.04M | 0.24% | 52 |
|
|
2015
Q4 | $13.1M | Buy |
259,946
+14,986
| +6% | +$756K | 0.33% | 37 |
|
|
2015
Q3 | $11.5M | Sell |
244,960
-82,103
| -25% | -$4.36M | 0.28% | 43 |
|
|
2015
Q2 | $17.8M | Buy |
327,063
+164,536
| +101% | +$9.23M | 0.54% | 32 |
|
|
2015
Q1 | $8.91M | Sell |
162,527
-97,254
| -37% | -$5.51M | 0.2% | 64 |
|
|
2014
Q4 | $14.1M | Sell |
259,781
-12,262
| -5% | -$683K | 0.31% | 38 |
|
|
2014
Q3 | $15.4M | Buy |
272,043
+60,050
| +28% | +$3.37M | 0.33% | 42 |
|
|
2014
Q2 | $11.7M | Buy |
211,993
+1,887
| +0.9% | +$103K | 0.35% | 52 |
|
|
2014
Q1 | $11.4M | Buy |
210,106
+27,248
| +15% | +$1.41M | 0.36% | 49 |
|
|
2013
Q4 | $8.73M | Sell |
182,858
-43,911
| -19% | -$2.01M | 0.36% | 54 |
|
|
2013
Q3 | $10.3M | Sell |
226,769
-1,572
| -0.7% | -$71.8K | 0.44% | 42 |
|
|
2013
Q2 | $10.1M | Buy |
+228,341
| New | +$10.2M | 0.45% | 45 |
|
Other funds holding MRK
Barings's MRK Position: Q3 2026 in Review
Barings reduced its Merck (MRK) stake by 25% in Q3 2026, selling an estimated $88.9K and leaving 1,914 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #162.
Barings first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. The position peaked at $17.8M in Q2 2015. 1,788 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Barings held 1,914 shares of Merck worth $278K as of Q3 2026.
- Barings sold 643 Merck shares in Q3 2026, an estimated $88.9K.
- Merck made up ﹤0.01% of Barings's portfolio in Q3 2026, its #162 holding.
- Barings first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
- Barings's Merck position peaked at $17.8M in Q2 2015.
- 1,788 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Barings's 13F filing for Q3 2026, filed 22 Oct 2026.